COLL: Collegium Pharmaceutical, Inc. Common Stock Company Profile & Statistics

About

Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and commercializes prescription and over-the-counter pharmaceuticals for the treatment of central nervous system, respiratory and skin related disorders. The Company's product candidate consists of COL-195, COL-196, COL-171, COL-003 and COL-172 which are in different clinical trial. It developed a formulation platform technology, DETERx, for the treatment of chronic pain. Collegium Pharmaceutical Inc. is based in CUMBERLAND, United States.

Info & Links

CEO

Joseph Ciaffoni

Headquarters

100 Technology Center Drive
Stoughton, MA 02072, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

Employees

197

Collegium Pharmaceutical, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

909.90M

Enterprise Value

1.71B

Enterprise Value/EBITDA(ttm)

5.05

Price to Earnings Ratio(ttm)

5.24

Price to Sales(ttm)

1.60

Price to Book(mrq)

4.09

Price to Cash(ytd)

2.76

Profitability

Gross Margin(ttm)

60.10%

Operating Margin(ttm)

37.92%

Profit Margin(ttm)

11.34%

Return on Equity(ttm)

104.67%

Return on Invested Capital(ttm)

9.67%

Return on Assets(ttm)

18.38%

Income Statement

Revenue(ttm)

599.25M

Revenue Per Share(ttm)

18.58

Gross Profit(ttm)

373.69M

EBITDA(ttm)³

339.36M

Net Income Available to Common(ttm)

88.59M

Diluted EPS(ttm)

2.32

Share Statistics

Beta (5Y Monthly)

0.82

52-Week Change

-22.28%

S&P 500 52-Week Change

12.74%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

32.25M

Dividend Yield

0.00%

Float⁴

30.97M

% Held by Insiders

3.98%

% Held by Institutions

Balance Sheet

Total Cash(mrq)

144.96M

Total Cash Per Share(mrq)

4.49

Total Debt(mrq)

867.21M

Total Debt/Equity(mrq)

372.52%

Current Ratio(mrq)

0.95%

Quick Ratio(mrq)

0.88%

Book Value Per Share(mrq)

7.28

Cash Flow

Operating Cash Flow Per Share(ytd)

5.07

Free Cash Flow(ytd)

203.33M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

COLL

Collegium Pharmaceutical, Inc. Common Stock

Collegium Pharmaceutical, Inc. Common Stock Profile